Bio-Rad Laboratories Stock Price (NYSE:BIO)

Add to My Stocks
$238.95 $3.53 (1.5%) BIO stock closing price Jul 26, 2017 (Closing)
Prev Close* : $235.42
Market Cap:
$6.97B
Day Low: $232.64
52 Week Low: $143.26
Open: $236.32
Volume: 165437
Day High: $239.91
52 Week High: $239.91
Dividend:
N/A

Latest Stock Market News

Latest Articles

Bio-Rad Laboratories News - From Partners

New Strong Sell Stocks for February 17th   by Zacks on Feb 17, 2017

BIO Stockcharts

View BIO PE ratio, PS ratio stocks charts and compare with peers.
BIO Chart
Note: Compare Bio-Rad Laboratories stock price history with the index and industry peers.

Bio-Rad Laboratories Valuation

PE ratio
(price earnings ratio)
254.2
PS ratio (
price to sales ratio
)
3.37
PB ratio (
price to book ratio
)
2.69

Bio-Rad Laboratories Returns

ROE
(return on equity)
1%

Bio-Rad Laboratories Financial Ratios

Asset Turnover
0.51
Receivables Turnover
5.64
Debt to Equity
0.16

BIO Industry Peers

Company Price Change (%)
Sunny Optical (SNPTF)11.850.45 (3.66%)
William Demant (WILYY)130 (0%)
Thermo Fisher Scientific (TMO)175.065.07 (2.81%)
Harvard Bioscience (HBIO)2.650.1 (3.92%)
Danaher (DHR)82.010.02 (0.02%)
Affymetrix (AFFX)14.010.02 (0.14%)
General Electric (GE)25.590.15 (0.59%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
TG Therapeutics (TGTX)11.80.45 (3.96%)
Chimerix (CMRX)5.120.14 (2.81%)
Enzymotec (ENZY)7.950.15 (1.92%)
Bio-Rad Laboratories (BIO)238.953.53 (1.5%)
Insys Therapeutics (INSY)12.030.16 (1.35%)
SurModics (SRDX)27.650.35 (1.28%)
LeMaitre Vascular (LMAT)28.90.32 (1.12%)
Top gainers from Medical Products industry
* As of Jul 27, 2017
CompanyPriceChange (%)
Eagle Pharma (EGRX)53.3716.67 (23.8%)
Oramed Pharma (ORMP)8.270.29 (3.39%)
Meridian Bioscience (VIVO)14.850.4 (2.62%)
Omeros (OMER)21.930.58 (2.58%)
Conatus Pharma (CNAT)5.960.13 (2.13%)
NuVasive (NUVA)79.461.58 (1.95%)
Rockwell Medical (RMTI)7.350.14 (1.87%)
Top losers from Medical Products industry
* As of Jul 27, 2017

Bio-Rad Laboratories, Inc. Stock News - Partner Headlines

Bio-Rad Laboratories Financial Statements

income statement20162015201420132012
Net Sales Or Revenues2.07B2.02B2.18B2.13B2.07B
Net Income28.12M113.09M88.84M77.78M163.77M
Total Operating Expense1.08B954.96M1.03B1.01B896.93M
view Bio-Rad Laboratories, Inc. income statement
balance sheet20162015201420132012
Total Assets3.85B3.71B3.34B3.39B3.44B
Total Liabilities1.26B1.22B1.16B1.2B1.43B
Shareholders Equity2.59B2.49B2.19B2.19B2.01B
view Bio-Rad Laboratories, Inc. balance sheet

Bio-Rad Laboratories Stock Message Board

Bio-Rad Laboratories stock lost 1.5 %, and the last close price as of 26 Jul, 2017 is 238.95 for BIO stock. Stock price or share price can be used to find the total market value of a company. Bio-Rad Laboratories market cap stands at 6.97B as of 26 Jul, 2017. A value investor must look at the fundamentals of a stock, and perform Bio-Rad Laboratories valuation, even though in the short-term sentiment and current breaking news might affect Bio-Rad Laboratories stock price.

The terms stocks and shares mean the same thing. For Ex: Bio-Rad Laboratories stock price and Bio-Rad Laboratories share price mean the same thing. The volume of shares traded stood at 165437 on the last trading day, as is evident from Bio-Rad Laboratories stock chart, and BIO stock quote data. Dividends are usually paid by large stable companies, and typically not by those which are in their rapid growth stages. A company's continuing success is indicated by a steadily increasing dividend payout. Bio-Rad Laboratories stock price history, gives the entire historical data for BIO stock.